ZIG
DGX icon

Zullo Investment Group’s Quest Diagnostics DGX Stock Holding History

Zullo Investment Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-280
Closed -$43.8K – 272
2022
Q4 		$43.8K Hold
280
– – 0.03% 290
2022
Q3 		$34K Hold
280
– – 0.02% 322
2022
Q2 		$37K Hold
280
– – 0.02% 314
2022
Q1 		$38K Hold
280
– – 0.02% 334
2021
Q4 		$48K Buy
+280
New +$42.6K 0.02% 310

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Zullo Investment Group's DGX Position: Q1 2023 in Review

Zullo Investment Group sold out of Quest Diagnostics (DGX) in Q1 2023, closing a stake of 280 shares — an estimated $43.8K sold.

Zullo Investment Group first reported a position in DGX in Q4 2021 and held it in 5 quarters. The position peaked at $48K in Q4 2021. 834 funds tracked by Wall St. Rank hold DGX as of Q1 2023.

  • Zullo Investment Group reported no remaining Quest Diagnostics position as of Q1 2023 after selling out during the quarter.
  • Zullo Investment Group sold 280 Quest Diagnostics shares in Q1 2023, an estimated $43.8K.
  • Zullo Investment Group first reported a position in Quest Diagnostics in Q4 2021 and held it in 5 quarters.
  • Zullo Investment Group's Quest Diagnostics position peaked at $48K in Q4 2021.
  • 834 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2023.

Based on Zullo Investment Group's 13F filing for Q1 2023, filed 25 Apr 2023.